231 related articles for article (PubMed ID: 23856330)
1. Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage.
Delbos V; Lemée L; Bénichou J; Berthelot G; Deghmane AE; Leroy JP; Houivet E; Hong E; Taha MK; Caron F;
Vaccine; 2013 Sep; 31(40):4416-20. PubMed ID: 23856330
[TBL] [Abstract][Full Text] [Related]
2. Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac.
Caron F; Delbos V; Houivet E; Deghmane AE; Leroy JP; Hong E; Bénichou J; Taha MK
Vaccine; 2012 Jul; 30(34):5059-62. PubMed ID: 22658929
[TBL] [Abstract][Full Text] [Related]
3. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease.
Norheim G; Arne Høiby E; Caugant DA; Namork E; Tangen T; Fritzsønn E; Rosenqvist E
Vaccine; 2004 Jun; 22(17-18):2171-80. PubMed ID: 15149774
[TBL] [Abstract][Full Text] [Related]
5. From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak.
Caron F; du Châtelet IP; Leroy JP; Ruckly C; Blanchard M; Bohic N; Massy N; Morer I; Floret D; Delbos V; Hong E; Révillion M; Berthelot G; Lemée L; Deghmane AE; Bénichou J; Lévy-Bruhl D; Taha MK
Lancet Infect Dis; 2011 Jun; 11(6):455-63. PubMed ID: 21489881
[TBL] [Abstract][Full Text] [Related]
6. Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.
Findlow J; Taylor S; Aase A; Horton R; Heyderman R; Southern J; Andrews N; Barchha R; Harrison E; Lowe A; Boxer E; Heaton C; Balmer P; Kaczmarski E; Oster P; Gorringe A; Borrow R; Miller E
Infect Immun; 2006 Aug; 74(8):4557-65. PubMed ID: 16861642
[TBL] [Abstract][Full Text] [Related]
7. Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease.
Nøkleby H; Aavitsland P; O'Hallahan J; Feiring B; Tilman S; Oster P
Vaccine; 2007 Apr; 25(16):3080-4. PubMed ID: 17287053
[TBL] [Abstract][Full Text] [Related]
8. Durability of immunogenicity and strain coverage of MenBvac, a meningococcal vaccine based on outer membrane vesicles: Lessons of the Normandy campaign.
Sevestre J; Hong E; Delbos V; Terrade A; Mallet E; Deghmane AE; Lemée L; Taha MK; Caron F
Vaccine; 2017 Jul; 35(32):4029-4033. PubMed ID: 28624305
[TBL] [Abstract][Full Text] [Related]
9. Prevention of meningococcal serogroup B infections in children: a protein-based vaccine induces immunologic memory.
de Kleijn ED; de Groot R; Lafeber AB; Labadie J; van Limpt CJ; Visser J; Berbers GA; van Alphen L; Rümke HC
J Infect Dis; 2001 Jul; 184(1):98-102. PubMed ID: 11398116
[TBL] [Abstract][Full Text] [Related]
10. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.
Kristiansen PA; Diomandé F; Ba AK; Sanou I; Ouédraogo AS; Ouédraogo R; Sangaré L; Kandolo D; Aké F; Saga IM; Clark TA; Misegades L; Martin SW; Thomas JD; Tiendrebeogo SR; Hassan-King M; Djingarey MH; Messonnier NE; Préziosi MP; Laforce FM; Caugant DA
Clin Infect Dis; 2013 Feb; 56(3):354-63. PubMed ID: 23087396
[TBL] [Abstract][Full Text] [Related]
11. Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines.
Heyderman RS; Davenport V; Williams NA
Trends Microbiol; 2006 Mar; 14(3):120-4. PubMed ID: 16469496
[TBL] [Abstract][Full Text] [Related]
12. Neisseria meningitidis B vaccines: recent advances and possible immunization policies.
Gasparini R; Amicizia D; Domnich A; Lai PL; Panatto D
Expert Rev Vaccines; 2014 Mar; 13(3):345-64. PubMed ID: 24476428
[TBL] [Abstract][Full Text] [Related]
13. Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.
Hou VC; Koeberling O; Welsch JA; Granoff DM
J Infect Dis; 2005 Aug; 192(4):580-90. PubMed ID: 16028126
[TBL] [Abstract][Full Text] [Related]
14. Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
Gorringe AR; Taylor S; Brookes C; Matheson M; Finney M; Kerr M; Hudson M; Findlow J; Borrow R; Andrews N; Kafatos G; Evans CM; Read RC
Clin Vaccine Immunol; 2009 Aug; 16(8):1113-20. PubMed ID: 19553555
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.
Snape MD; Dawson T; Oster P; Evans A; John TM; Ohene-Kena B; Findlow J; Yu LM; Borrow R; Ypma E; Toneatto D; Pollard AJ
Pediatr Infect Dis J; 2010 Nov; 29(11):e71-9. PubMed ID: 20844462
[TBL] [Abstract][Full Text] [Related]
16. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.
Pajon R; Buckwalter CM; Johswich KO; Gray-Owen SD; Granoff DM
Vaccine; 2015 Mar; 33(11):1317-1323. PubMed ID: 25662856
[TBL] [Abstract][Full Text] [Related]
17. An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt.
Norheim G; Tunheim G; Næss LM; Kristiansen PA; Caugant DA; Rosenqvist E
Scand J Immunol; 2012 Aug; 76(2):99-107. PubMed ID: 22537024
[TBL] [Abstract][Full Text] [Related]
18. Predicted vs observed effectiveness of outer membrane vesicle (OMV) vaccines against meningococcal serogroup B disease: Systematic review.
Harder T; Koch J; Wichmann O; Hellenbrand W
J Infect; 2017 Aug; 75(2):81-94. PubMed ID: 28487177
[TBL] [Abstract][Full Text] [Related]
19. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.
Tunheim G; Naess LM; Acevedo R; Fjeldheim ÅK; Bolstad K; García L; Cardoso D; Aase A; Zayas C; González H; Rosenqvist E; Norheim G
Vaccine; 2014 Nov; 32(49):6631-8. PubMed ID: 25305564
[TBL] [Abstract][Full Text] [Related]
20. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
Toropainen M; Saarinen L; Wedege E; Bolstad K; Mäkelä PH; Käyhty H
Vaccine; 2005 Sep; 23(40):4821-33. PubMed ID: 15970361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
